The groundbreaking approach of the medication represents a exciting development in the care of the condition. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide752736.bloggip.com/42465008/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment